|

Anxiety and Depression in Adolescent PCOS

RECRUITINGN/ASponsored by Ege University
Actively Recruiting
PhaseN/A
SponsorEge University
Started2025-08-17
Est. completion2026-03-17
Eligibility
Age15 Years – 19 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07127458

Summary

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder in adolescent females, often accompanied by psychological symptoms such as anxiety and depression. These conditions are frequently underdiagnosed and untreated. This study aims to determine the prevalence of anxiety and depression in adolescents with PCOS and to assess changes following oral contraceptive use.

Eligibility

Age: 15 Years – 19 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Age between 15 and 19 years
* Diagnosis of adolescent polycystic ovary syndrome (PCOS)

Exclusion Criteria:

* Severe reading or comprehension difficulties
* Severe hearing impairment
* Current use of hormone therapy
* Presence of a virilizing tumor
* Major psychiatric disorders such as schizophrenia, bipolar disorder, or dissociative disorder

Conditions4

AnxietyCancerDepressionPCOS (Polycystic Ovary Syndrome)

Browse More Trials

Cancer trialsDepression trialsAnxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.